Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …

Non–small cell lung cancer (NSCLC) is the most abundant type of epithelial lung cancer
being diagnosed after 40% of invasions of excrescence in pulmonary tissues. According to …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Although isolated local (LRs) and regional recurrences (RRs) constitute a minority of post-
stereotactic ablative radiotherapy (SABR) relapses, their management is becoming …

The purpose of this article is to provide an update on evidence-based methods for
mediastinal staging in patients with lung cancer. This is a review of the recently published …

Stereotactic body radiotherapy (SBRT) is an alternative to surgery for patients with early
stage non-small cell lung cancer (NSCLC) who are inoperable due to comorbid disease or …

Purpose A common pattern of recurrence in lung cancer after receiving full dose external
beam radiation therapy (EBRT) to targeted sites is isolated mediastinal and hilar recurrence …

Intrathoracic recurrence after carbon‐ion radiotherapy for primary or metastatic lung tumors
remains a major cause of cancer‐related deaths. However, treatment options are limited …

Introduction Isolated nodal failure (INF) without synchronous local or distant failure is an
uncommon occurrence after stereotactic body radiation therapy (SBRT) for lung cancer …

Introduction The objective of this study was to determine the predictors and patterns of
regional recurrence (RR) following stereotactic body radiotherapy (SBRT) for primary lung …